Literature DB >> 12916926

The effect of cosolvents on the formulation of nanoparticles from low-molecular-weight poly(l)lactide.

Leena Peltonen1, Piritta Koistinen, Milja Karjalainen, Antti Häkkinen, Jouni Hirvonen.   

Abstract

The aim of this study was to formulate nanoparticles from poly(l)lactide by a modified nanoprecipitation method. The main focus was to study the effect of cosolvent selection on the shape, size, formation efficiency, degree of crystallinity, x-ray diffraction (XRD) reflection pattern, and zeta potential value of the particles. Low-molecular-weight (2000 g/mol) poly(l)lactide was used as a polymer, and sodium cromoglycate was used as a drug. Acetone, ethanol, and methanol were selected as cosolvents. Optimal nanoparticles were achieved with ethanol as a cosolvent, and the formation efficiency of the particles was also higher with ethanol as compared with acetone or methanol. The particles formulated by ethanol and acetone appeared round and smooth, while with methanol they were slightly angular. When the volume of the inner phase was decreased during the nanoprecipitation process, the mean particle size was also decreased with all the solvents, but the particles were more prone to aggregate. The XRD reflection pattern and the degree of crystallinity were more dependent on the amount of the solvents in the inner phase than on the properties of the individual cosolvents. The zeta potential values of all the particle batches were slightly negative, which partially explains the increased tendency toward particle aggregation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12916926      PMCID: PMC2751340          DOI: 10.1208/pt030432

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  17 in total

1.  Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats.

Authors:  Q Zhang; Z Shen; T Nagai
Journal:  Int J Pharm       Date:  2001-05-07       Impact factor: 5.875

2.  Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method.

Authors:  H Murakami; M Kobayashi; H Takeuchi; Y Kawashima
Journal:  Int J Pharm       Date:  1999-10-05       Impact factor: 5.875

3.  Preparation of nanoparticles composed with bioinspired 2-methacryloyloxyethyl phosphorylcholine polymer.

Authors:  T Konno; K Kurita; Y Iwasaki; N Nakabayashi; K Ishihara
Journal:  Biomaterials       Date:  2001-07       Impact factor: 12.479

4.  Jejunal absorption, pharmacological activity, and pharmacokinetic evaluation of indomethacin-loaded poly(d,l-lactide) and poly(isobutyl-cyanoacrylate) nanocapsules in rats.

Authors:  N Ammoury; H Fessi; J P Devissaguet; M Dubrasquet; S Benita
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

5.  Solid-state behavior of cromolyn sodium hydrates.

Authors:  L R Chen; V G Young; D Lechuga-Ballesteros; D J Grant
Journal:  J Pharm Sci       Date:  1999-11       Impact factor: 3.534

6.  Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology.

Authors:  Todd M Martin; Nagesh Bandi; Ryan Shulz; Christopher B Roberts; Uday B Kompella
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

7.  A bioresorbable, polylactide reservoir for diffusional and osmotically controlled drug delivery.

Authors:  S Jonnalagadda; D H Robinson
Journal:  AAPS PharmSciTech       Date:  2000-10-03       Impact factor: 3.246

8.  Long-term release of clodronate from biodegradable microspheres.

Authors:  P Perugini; I Genta; B Conti; T Modena; F Pavanetto
Journal:  AAPS PharmSciTech       Date:  2001-07-11       Impact factor: 3.246

9.  A novel in vitro release technique for peptide containing biodegradable microspheres.

Authors:  J W Kostanski; P P DeLuca
Journal:  AAPS PharmSciTech       Date:  2000-03-09       Impact factor: 3.246

10.  Solid-state chemistry of cromolyn sodium (disodium cromoglycate).

Authors:  J S Cox; G D Woodard; W C McCrone
Journal:  J Pharm Sci       Date:  1971-10       Impact factor: 3.534

View more
  7 in total

1.  Nanoparticles containing ketoprofen and acrylic polymers prepared by an aerosol flow reactor method.

Authors:  Hannele Eerikäinen; Leena Peltonen; Janne Raula; Jouni Hirvonen; Esko I Kauppinen
Journal:  AAPS PharmSciTech       Date:  2004-09-23       Impact factor: 3.246

2.  Improved entrapment efficiency of hydrophilic drug substance during nanoprecipitation of poly(l)lactide nanoparticles.

Authors:  Leena Peltonen; Johanna Aitta; Samuli Hyvönen; Milja Karjalainen; Jouni Hirvonen
Journal:  AAPS PharmSciTech       Date:  2004-03-08       Impact factor: 3.246

3.  Long-term release of a thiobenzamide from a backbone functionalized poly(lactic acid).

Authors:  Tyler R Long; Amaraporn Wongrakpanich; Anh-Vu Do; Aliasger K Salem; Ned B Bowden
Journal:  Polym Chem       Date:  2015-09-04       Impact factor: 5.364

4.  Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™.

Authors:  Jagdishbhai L Italia; Andrew Sharp; Katharine C Carter; Peter Warn; M N V Ravi Kumar
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

5.  Evaluation of In Vivo Transfection Efficiency of Eudragit Coated Nanoparticles of Chitosan-DNA: A pH-sensitive System Prepared for Oral DNA Delivery.

Authors:  Sedigheh Momenzadeh; Abdorrahim Sadeghi; Nasimeh Vatandoust; Rasoul Salehi
Journal:  Iran Red Crescent Med J       Date:  2015-04-25       Impact factor: 0.611

6.  Rivastigmine-loaded L-lactide-depsipeptide polymeric nanoparticles: decisive formulation variable optimization.

Authors:  Kunal Pagar; Pradeep Vavia
Journal:  Sci Pharm       Date:  2013-03-28

7.  Formulation optimization of sustained-release ammonio methacrylate copolymer microspheres. Effects of log p and concentration of polar cosolvents, and role of the drug/copolymer ratio.

Authors:  Péter Sipos; Róbert Rajkó; Klára Pintye-Hódi; István Erős; Piroska Szabó-Révész
Journal:  Pharmaceutics       Date:  2011-11-10       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.